Takeda Pharmaceutical Co Ltd
NYSE:TAK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Takeda Pharmaceutical Co Ltd
NYSE:TAK
|
JP |
|
Evolent Health Inc
NYSE:EVH
|
US |
|
N
|
Newmont Corporation
TSX:NGT
|
US |
Wall Street
Price Targets
TAK Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
TAK
is 19.78 USD
with a low forecast of 15.31 USD and a high forecast of 26.42 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TAK's stock price target?
Price Target
19.78
USD
According to Wall Street analysts, the average 1-year price target for
TAK
is 19.78 USD
with a low forecast of 15.31 USD and a high forecast of 26.42 USD.
What is Takeda Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
1%
For the last 13 years the
compound annual growth rate for
Takeda Pharmaceutical Co Ltd's revenue is
9%.
The projected
CAGR
for the next 3 years is
1%.
What is Takeda Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-5%
For the last 13 years the
compound annual growth rate for
Takeda Pharmaceutical Co Ltd's operating income is
6%.
The projected
CAGR
for the next 2 years is
-5%.
What is Takeda Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
45%
For the last 13 years the
compound annual growth rate for
Takeda Pharmaceutical Co Ltd's net income is
-1%.
The projected
CAGR
for the next 3 years is
45%.
